Subcutaneous or intramuscular injectable pegylated recombinant interferon alfa-2b for immunomodulatory therapy. Used in oncology and hepatology departments for melanoma and viral-associated cancers. Distributed by pharmaceutical companies to hospitals and clinics, purchased by procurement teams for therapeutic applications in specialized care